AMRX
Price
$8.06
Change
+$0.06 (+0.75%)
Updated
Jul 25 closing price
Capitalization
1.87B
10 days until earnings call
ZTS
Price
$151.98
Change
-$0.84 (-0.55%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
77.48B
10 days until earnings call
Interact to see
Advertisement

AMRX vs ZTS

Header iconAMRX vs ZTS Comparison
Open Charts AMRX vs ZTSBanner chart's image
Amneal Pharmaceuticals
Price$8.06
Change+$0.06 (+0.75%)
Volume$1.12M
Capitalization1.87B
ZOETIS
Price$151.98
Change-$0.84 (-0.55%)
Volume$48.74K
Capitalization77.48B
AMRX vs ZTS Comparison Chart in %
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. ZTS commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and ZTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (AMRX: $8.06 vs. ZTS: $152.12)
Brand notoriety: AMRX: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 71% vs. ZTS: 114%
Market capitalization -- AMRX: $1.87B vs. ZTS: $77.48B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMRX and ZTS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while ZTS’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 4 bearish.
  • ZTS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ZTS is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.13% price change this week, while ZTS (@Pharmaceuticals: Other) price change was +2.37% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 05, 2025.

ZTS is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than ZTS: AMRX (90.00) vs ZTS (32.94). AMRX YTD gains are higher at: 1.768 vs. ZTS (-5.288). ZTS has higher annual earnings (EBITDA): 3.67B vs. AMRX (400M). ZTS has more cash in the bank: 2.04B vs. AMRX (91.5M). AMRX has less debt than ZTS: AMRX (2.75B) vs ZTS (6.76B). ZTS has higher revenues than AMRX: ZTS (8.54B) vs AMRX (2.39B).
AMRXZTSAMRX / ZTS
Capitalization1.87B77.5B2%
EBITDA400M3.67B11%
Gain YTD1.768-5.288-33%
P/E Ratio90.0032.94273%
Revenue2.39B8.54B28%
Total Cash91.5M2.04B4%
Total Debt2.75B6.76B41%
FUNDAMENTALS RATINGS
AMRX vs ZTS: Fundamental Ratings
AMRX
ZTS
OUTLOOK RATING
1..100
6559
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
5978
SMR RATING
1..100
9919
PRICE GROWTH RATING
1..100
5861
P/E GROWTH RATING
1..100
2779
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZTS's Valuation (61) in the Pharmaceuticals Generic industry is in the same range as AMRX (92) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (59) in the Pharmaceuticals Major industry is in the same range as ZTS (78) in the Pharmaceuticals Generic industry. This means that AMRX’s stock grew similarly to ZTS’s over the last 12 months.

ZTS's SMR Rating (19) in the Pharmaceuticals Generic industry is significantly better than the same rating for AMRX (99) in the Pharmaceuticals Major industry. This means that ZTS’s stock grew significantly faster than AMRX’s over the last 12 months.

AMRX's Price Growth Rating (58) in the Pharmaceuticals Major industry is in the same range as ZTS (61) in the Pharmaceuticals Generic industry. This means that AMRX’s stock grew similarly to ZTS’s over the last 12 months.

AMRX's P/E Growth Rating (27) in the Pharmaceuticals Major industry is somewhat better than the same rating for ZTS (79) in the Pharmaceuticals Generic industry. This means that AMRX’s stock grew somewhat faster than ZTS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXZTS
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
61%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 3 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 3 days ago
58%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 6 days ago
55%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 3 days ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IVW113.290.23
+0.20%
iShares S&P 500 Growth ETF
PGMFF26.29N/A
N/A
Barclays Bank PLC
BBBI51.28-0.03
-0.06%
BondBloxx BBB Rated 5-10 Yr Corp Bd ETF
FGD28.69-0.13
-0.45%
First Trust Dow Jones Global Sel Div ETF
RZV109.92-2.70
-2.40%
Invesco S&P SmallCap 600® Pure Value ETF

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.75%
PAHC - AMRX
47%
Loosely correlated
-0.88%
VTRS - AMRX
45%
Loosely correlated
+0.64%
AMPH - AMRX
40%
Loosely correlated
-1.15%
EBS - AMRX
39%
Loosely correlated
-4.02%
ZTS - AMRX
39%
Loosely correlated
-0.46%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with ELAN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-0.41%
ELAN - ZTS
48%
Loosely correlated
-2.20%
VTRS - ZTS
44%
Loosely correlated
-0.21%
PAHC - ZTS
41%
Loosely correlated
-1.17%
AMRX - ZTS
39%
Loosely correlated
-0.87%
HLN - ZTS
37%
Loosely correlated
+1.03%
More